CYTOKINETICS INCORPOR

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 апр 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis

31 мар 2023 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Releases Inaugural Corporate Responsibility Report

27 мар 2023 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Participate in Upcoming Investor Conferences

06 мар 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session

04 мар 2023 09:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 мар 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Reports Fourth Quarter 2022 Financial Results

01 мар 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil

28 фев 2023 16:31:51 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session

24 фев 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

22 фев 2023 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Announce Fourth Quarter Results on March 1, 2023

15 фев 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 фев 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program

30 янв 2023 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 янв 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

03 янв 2023 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil

13 дек 2022 16:45:52 Источник Nasdaq GlobeNewswire

Cytokinetics Stock Trading Halted Today

13 дек 2022 06:02:16 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

09 дек 2022 07:59:34 Источник Nasdaq GlobeNewswire

Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND

08 дек 2022 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136

07 дек 2022 06:30:00 Источник Nasdaq GlobeNewswire